Agrisera High-Quality Polyclonal and Monoclonal Antibody Services
Agrisera is a Swedish company which specialises in polyclonal and monoclonal antibody production. We take pride in our high service level and our antibodies that really work. We have been in business for nearly 30 years and have close collaboration with research groups and pharmaceutical companies around the globe. Agrisera follows strict quality guidelines and is approved by National Institutes of Health (NIH).
Monoclonal and polyclonal custom made antibodies
Agrisera offer a complete range of services for the production of custom made antibodies, both monoclonals and polyclonals. We can assist in designing or producing the antigen, raising the antibody all the way to a purified and labelled antibody.
Cell fusion developed monoclonals
We have longstanding experience in developing monoclonals, including cell fusion and hybridoma selection as well as scale-up of production using cell cultures. Our antibody shop offers a number of exclusive antibodies produced in collaboration with leading research groups, e.g. Alzheimer’s research antibodies specific to amyloid beta oligomers.
Custom made polyclonals
Agrisera has over the years produced polyclonal antibodies against several thousand different antigens. Custom made polyclonals are produced in rabbit, goat, hen, rat and mice. Our immunization programs are optimised to obtain antibodies of high titre and specificity. We are always willing to discuss different demands regarding the length of the program, antigen doses and administration.
Antigens and peptide synthesized design
Peptides can be designed and synthesized according to your requirements. Agrisera offers a complete service in this area and has longstanding experience in selecting peptides that work in specific applications. We also offer recombinant production of large peptides for immunisation.
Purification and antibody labelling
We perform affinity purification of IgG, IgM and IgY for applications such as immunoprecipitation, immunohistochemistry and antibody labelling. Labelling of antibodies with enzymes for use in ELISA and other immunochemical techniques is performed according to client needs.
Agrisera also performs immunogenicity studies for pharmaceutical companies. The studies are conducted following strict secrecy and ethical guidelines.
All off-the-shelf antibodies from Agrisera are accompanied with full documentation including instructions of use. Agrisera is approved by the National Institute of Health. The Agrisera NIH assurance number is; A5783-01.
Sendai virus for R&D and drug production
Since 1980 Agrisera have produced Sendai virus, which is used by drug companies for R&D and drug production. The virus production has been carried out in accordance with ever-increasing demands from the drug industry. For more information please contact us.
Products and Services
Fujifilm Corporation and Merck, known as MSD outside the US and Canada, have announced that they have entered into a definitive agreement by which Fujifilm will acquire the Merck BioManufacturing Network, a leading provider of contract manufacturing and development services for the biopharmaceutRead more
ACE Pharmaceuticals today announced that the first patient has entered the Phase III trial also known as the Levamisole trial. This trial was accepted by the EMEA by November 2006. The goal of this trial, which was accepted by the EMEA in November 2006, is to assess the efficacy and saRead more
PROTEO Biotech AG and ARTES Biotechnology GmbH: Strategic Alliance for Marketing of Elafin in Asia, Africa and South America
Kiel - Erkrath, June 19, 2006. PROTEO Biotech AG, a wholly owned subsidiary of PROTEO Inc., USA, has signed a cooperation agreement with ARTES Biotechnology GmbH. The aim of the agreement is the marketing of Elafin, the lead product of PROTEO Biotech AG / PROTEO Inc., in India, Egypt and ArgentinRead more